HIV: the generic version of lenacapavir, a drug that promises to revolutionize the fight against the AIDS virus, ready to be marketed

Dr. Reddy’s has received FDA approval for a generic version of lenacapavir, a long-acting preventive treatment for HIV. This marks a significant milestone in the fight against AIDS, especially in Africa. Unlike daily PrEP pills, lenacapavir requires only two injections per year. It will be priced at $40 annually in 120 low- and middle-income countries, with initial stocks expected by the end of the year.